Effects of Cyproterone Acetate on Adrenal Steroidogenesis in vitro

Abstract

The effects of cyproterone acetate (CA) on steroidogenesis in isolated guinea-pig adrenal cells have been investigated by measuring the production of cortisol, its immediate precursors (11-deoxycortisol and 17-hydroxyprogesterone), and adrenal androgens (Δ⁴-androstenedione and dehydroepiandrosterone). Used at a dose of 2 µg/ml, CA provoked a sharp drop in the production of cortisol, aldosterone and 11-deoxycortisol. By contrast, 17-hydroxyprogesterone, Δ⁴-androstenedione and dehydroepiandrosterone were increased, which suggests that 21 -hydroxylase activity is inhibited. With concentrations above 2 µg/ml CA, it would seem to be the 3-β-ol-dehydrogenase-Δ^4,5-isomerase complex that is affected, since dehydroepiandrosterone exhibited a sudden increase, whereas 17-hydroxyprogesterone and Δ⁴-androstenedione showed a relative decrease. The enzymatic system or systems involved therefore appear to be linked to the concentration of CA used but, whatever the case, the drop in cortisol production is accompanied by a decrease in aldosterone and an increase in adrenal androgen levels.

Environmental-endocrine control of reproductive maturation in gastropods: implications for the mechanism of tributyltin-induced imposex in prosobranchs

“…At sufficiently high Environmental-endocrine control of reproductive maturation in gastropods 15 dosages, cyproterone acetate might also inhibit other nuclear receptors such as RXR. Furthermore, cyproterone acetate is capable of inhibiting the action of enzymes that are involved in hormonal biosynthetic pathways (Ayub and Levell 1987;Pham-Huu-Trung et al 1984). Therefore, this compound may elicit multiple effects on hormone signaling pathways beyond its recognized ability to inhibit androgen signaling.…”

The transcriptional programme of the androgen receptor (AR) in prostate cancer

“…This explains why treatment withdrawal can sometimes be effective in advanced disease . Cyproterone acetate is another AR antagonist traditionally used to cover for LHRH‐analogue flare, which also has some anti‐gonadotrophic and steroid biosynthesis effects . Enzalutamide (MDV3100) is a more potent antagonist of the AR, which disrupts nuclear AR translocation and DNA binding, as well as preventing co‐activator recruitment .…”

Biopotency and site of action of drugs affecting testicular steroidogenesis

“…Two sites of action have been defined for cyproterone acetate, namely 3ß-hydroxysteroid dehydrogenase and 21-hydroxylase (Pham-Huu-Trung et al 1984;Lambert et al 19856). Epostane has been shown to suppress adrenal steroidogenesis by inhibiting 3ß-hydroxysteroid dehydrogenase (van der Spuy et al…”

“…Spuy et al 1983;Fry & Griffiths, 1984;Kenyon et al 1984;Pham-Huu-Trung et al 1984). Where enzymic sites are common to both steroidogenic pathways, the sites of the anti-adrenal and antitesticular effects of the drugs are…”